178
Views
14
CrossRef citations to date
0
Altmetric
Original

Flt3-ITD mutations can generate leukaemia specific neoepitopes: Potential role for immunotherapeutic approaches

, , &
Pages 307-312 | Received 28 Jul 2005, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Marie Bleakley, Cameron J Turtle & Stanley R Riddell. (2012) Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantation. Expert Review of Hematology 5:4, pages 409-425.
Read now

Articles from other publishers (13)

Weijun Zhou, Jinyi Yu, Yilu Li & Kankan Wang. (2022) Neoantigen-specific TCR-T cell-based immunotherapy for acute myeloid leukemia. Experimental Hematology & Oncology 11:1.
Crossref
Pujan R. Patel, Maureen C. Farrell, Ani Peshtani & Meghan K. Berkenstock. (2022) Bilateral anterior and posterior scleritis in a patient with acute myelogenous leukemia. American Journal of Ophthalmology Case Reports 26, pages 101497.
Crossref
Ming Wu, Sheng Wang, Jian-Yu Chen, Li-Juan Zhou, Zi-Wen Guo & Yu-Hua Li. (2021) Therapeutic cancer vaccine therapy for acute myeloid leukemia. Immunotherapy 13:10, pages 863-877.
Crossref
Malte Roerden, Annika Nelde & Juliane S. Walz. (2019) Neoantigens in Hematological Malignancies—Ultimate Targets for Immunotherapy?. Frontiers in Immunology 10.
Crossref
Aditi Singh, Nikolai Norevik Myklebust, Sarah Marie Vie Furevik, Ragnhild Haugse & Lars Herfindal. (2019) Immunoliposomes in Acute Myeloid Leukaemia Therapy: An Overview of Possible Targets and Obstacles. Current Medicinal Chemistry 26:28, pages 5278-5292.
Crossref
Nessar Ahmad Azrakhsh, Patrycja Mensah-glanowska, Kristoffer Sand & Astrid Olsnes Kittang. (2019) Targeting Immune Signaling Pathways in Clonal Hematopoiesis. Current Medicinal Chemistry 26:28, pages 5262-5277.
Crossref
Morten Orebo Holmström & Hans Carl Hasselbalch. (2018) Cancer immune therapy for myeloid malignancies: present and future. Seminars in Immunopathology 41:1, pages 97-109.
Crossref
Rebecca Austin, Mark J. Smyth & Steven W. Lane. (2016) Harnessing the immune system in acute myeloid leukaemia. Critical Reviews in Oncology/Hematology 103, pages 62-77.
Crossref
C Riether, C M Schürch & A F Ochsenbein. (2014) Regulation of hematopoietic and leukemic stem cells by the immune system. Cell Death & Differentiation 22:2, pages 187-198.
Crossref
Jason B. BrayerJavier Pinilla-Ibarz. (2013) Developing Strategies in the Immunotherapy of Leukemias. Cancer Control 20:1, pages 49-59.
Crossref
S Anguille, V F Van Tendeloo & Z N Berneman. (2012) Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia. Leukemia 26:10, pages 2186-2196.
Crossref
Tamás Bubán, Katalin Koczok, Róza Földesi, Gabriella Szabó, Andrea Sümegi, Miklós Tanyi, László Szerafin, Miklós Udvardy, János Kappelmayer & Péter Antal-Szalmás. (2012) Detection of internal tandem duplications in the FLT3 gene by different electrophoretic methods. Clinical Chemistry and Laboratory Medicine (CCLM) 50:2.
Crossref
Claudine Graf, Florian Heidel, Stefan Tenzer, Markus P. Radsak, Fian K. Solem, Cedrik M. Britten, Christoph Huber, Thomas Fischer & Thomas Wölfel. (2006) A neoepitope generated by an FLT3 internal tandem duplication (FLT3-ITD) is recognized by leukemia-reactive autologous CD8+ T cells. Blood 109:7, pages 2985-2988.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.